Because of advances in drug design and precision medicine, researchers have been able to target certain molecules within a cell at the root of a particular disease and to develop specific therapies to undo their damages. ...
Apr 4, 2018
0
4
Cancer therapies that target a specific protein have improved outcomes for patients. However, many patients eventually develop resistance to these targeted therapies and their cancer comes back. It is believed that differences ...
Apr 3, 2018
0
20
Cancer continues to be a deadly threat to more than 14 million people who are diagnosed each year around the world. At the same time, five-year survival rates have been steadily improving over the last three decades to nearly ...
Mar 15, 2018
0
37
Nearly half of Canadians will develop cancer in their lifetime, according to the Canadian Cancer Society. Globally, cancer is the second leading cause of death.
Feb 28, 2018
0
5
Researchers at Queen Mary University of London have discovered that the loss of a single protein- PHLDA1- is sufficient for the development of drug resistance to a type of targeted therapy in endometrial and HER2-positive ...
Feb 27, 2018
0
13
Scientists from the Universities of Bristol and Parma, Italy, have used molecular simulations to understand resistance to osimertinib - an anticancer drug used to treat types of lung cancer.
Feb 12, 2018
0
63
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.
Jan 23, 2018
0
27
Kris Wood, PhD, had been going full tilt for more than six months, ever since he'd been hired to the faculty in the Department of Pharmacology and Cancer Biology at Duke. He was working 12 stressful hours a day, adjusting ...
Oct 26, 2017
0
1
Cancer cells that survive after treatment may use the body's own immune system to wake themselves up and fuel their growth, a new study shows.
Oct 16, 2017
0
2
Research led by Dr. Carlos Arteaga, Director of the Harold C. Simmons Comprehensive Cancer Center, has identified potential targets for treatment of triple negative breast cancer, the most aggressive form of breast cancer.
Oct 3, 2017
0
0
